These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 26091704)

  • 61. A comparison of CT- and MR-based attenuation correction in neurological PET.
    Dickson JC; O'Meara C; Barnes A
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1176-89. PubMed ID: 24425423
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PET/CT imaging: effect of respiratory motion on apparent myocardial uptake.
    Le Meunier L; Maass-Moreno R; Carrasquillo JA; Dieckmann W; Bacharach SL
    J Nucl Cardiol; 2006 Nov; 13(6):821-30. PubMed ID: 17174813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction.
    Eiber M; Souvatzoglou M; Pickhard A; Loeffelbein DJ; Knopf A; Holzapfel K; Martinez-Möller A; Nekolla SG; Scherer EQ; Schwaiger M; Rummeny EJ; Beer AJ
    Eur J Radiol; 2012 Oct; 81(10):2658-65. PubMed ID: 22078793
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Feasibility of using respiration-averaged MR images for attenuation correction of cardiac PET/MR imaging.
    Ai H; Pan T
    J Appl Clin Med Phys; 2015 Jul; 16(4):311-321. PubMed ID: 26218995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Simultaneous reconstruction of activity and attenuation for PET/MR.
    Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
    IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Assessment of Emission- and Segmentation-Based MR-Guided Attenuation Correction in Whole-Body Time-of-Flight PET/MR Imaging.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Jun; 56(6):877-83. PubMed ID: 25858043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
    Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
    AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Integrated PET/MR.
    Quick HH
    J Magn Reson Imaging; 2014 Feb; 39(2):243-58. PubMed ID: 24338921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows.
    Beyer T; Rosenbaum S; Veit P; Stattaus J; Müller SP; Difilippo FP; Schöder H; Mawlawi O; Roberts F; Bockisch A; Kühl H
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1429-39. PubMed ID: 16133383
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Description and assessment of a registration-based approach to include bones for attenuation correction of whole-body PET/MRI.
    Marshall HR; Patrick J; Laidley D; Prato FS; Butler J; Théberge J; Thompson RT; Stodilka RZ
    Med Phys; 2013 Aug; 40(8):082509. PubMed ID: 23927354
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Effect of Susceptibility Artifacts Related to Metallic Implants on Adjacent-Lesion Assessment in Simultaneous TOF PET/MR.
    Svirydenka H; Delso G; De Galiza Barbosa F; Huellner M; Davison H; Fanti S; Veit-Haibach P; Ter Voert EEGW
    J Nucl Med; 2017 Jul; 58(7):1167-1173. PubMed ID: 28062597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of myocardial perfusion 82Rb PET performed with CT- and transmission CT-based attenuation correction.
    Slomka PJ; Le Meunier L; Hayes SW; Acampa W; Oba M; Haemer GG; Berman DS; Germano G
    J Nucl Med; 2008 Dec; 49(12):1992-8. PubMed ID: 19038996
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correction.
    Samarin A; Burger C; Wollenweber SD; Crook DW; Burger IA; Schmid DT; von Schulthess GK; Kuhn FP
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1154-60. PubMed ID: 22526955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI.
    Lassen ML; Rasul S; Beitzke D; Stelzmüller ME; Cal-Gonzalez J; Hacker M; Beyer T
    J Nucl Cardiol; 2019 Aug; 26(4):1107-1118. PubMed ID: 29168158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI.
    Beiderwellen K; Gomez B; Buchbender C; Hartung V; Poeppel TD; Nensa F; Kuehl H; Bockisch A; Lauenstein TC
    Eur J Radiol; 2013 Nov; 82(11):e669-75. PubMed ID: 24011443
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Joint estimation of activity and attenuation for PET using pragmatic MR-based prior: application to clinical TOF PET/MR whole-body data for FDG and non-FDG tracers.
    Ahn S; Cheng L; Shanbhag DD; Qian H; Kaushik SS; Jansen FP; Wiesinger F
    Phys Med Biol; 2018 Feb; 63(4):045006. PubMed ID: 29345242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.